Medical Research
(H20)
990 on File
INTERNATIONAL MAMMALIAN GENOME SOCIETY INC
Financial strength (30%)
63/100
Reliability (20%)
55/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$178K
Total Revenue
$134K
Total Expenses
$370K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
33.01x
Liability-to-Asset
N/A
Revenue Diversification
53.3%
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 84.6% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
33.0 mo | 11.7 mo |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
53.3% | 92.2% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
76.8% | 3.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
94.1% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
24.4% | -1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $178K | $134K | $370K | 100.0% | — |
| 2024 | $100K | $69K | $326K | 100.0% | — |
| 2023 | $173K | $164K | $295K | 100.0% | — |
| 2022 | $13K | $23K | $287K | 98.7% | — |
| 2021 | $105K | $19K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.